NEUROLEUKIN Trademark

Trademark Overview

On Thursday, September 24, 2020, a trademark application was filed for NEUROLEUKIN with the United States Patent and Trademark Office. The USPTO has given the NEUROLEUKIN trademark a serial number of 90205865. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, September 6, 2022. This trademark is owned by Therapeutic Solutions International, Inc.. The NEUROLEUKIN trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for the treatment of depression and schizophrenia all for suicide prevention
neuroleukin

General Information

Serial Number90205865
Word MarkNEUROLEUKIN
Filing DateThursday, September 24, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, September 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological preparations for the treatment of depression and schizophrenia all for suicide prevention

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 2, 2020
Primary Code005
First Use Anywhere DateTuesday, June 15, 2021
First Use In Commerce DateTuesday, June 15, 2021

Trademark Owner History

Party NameTherapeutic Solutions International, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOceanside, CA 92056

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, September 6, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, February 22, 2022NON-FINAL ACTION WRITTEN
Wednesday, January 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 26, 2022ASSIGNED TO LIE
Friday, January 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2021NON-FINAL ACTION E-MAILED
Wednesday, July 21, 2021NON-FINAL ACTION WRITTEN
Saturday, July 10, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Friday, July 9, 2021USE AMENDMENT ACCEPTED
Tuesday, June 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 21, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 21, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 22, 2021AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, June 22, 2021USE AMENDMENT FILED
Monday, June 21, 2021TEAS AMENDMENT OF USE RECEIVED
Monday, December 21, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 21, 2020NON-FINAL ACTION E-MAILED
Monday, December 21, 2020NON-FINAL ACTION WRITTEN
Thursday, December 17, 2020ASSIGNED TO EXAMINER
Tuesday, December 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 15, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 15, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 28, 2020NEW APPLICATION ENTERED

Related Keywords

neuroleukin suicide prevention schizophrenia depression preparations treatment biological